Condition
Malignant Pleural Disease|Mesothelioma|Metastases|Lung Cancer|Breast Cancer
Estimated Enrollment: 24
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: No masking|Primary Purpose: Treatment
Study ID Numbers: 15-007
Study First Received: April 2, 2015
Last Updated: April 6, 2017
Estimated Primary Completion Date: April 2018
Primary Outcome Measures:
Composite measure of severity and number of adverse events (AEs); changes in clinical laboratory test findings (hematologic and chemistry); and physical examination.|Changes in serum levels of the biomarker soluble mesothelin related peptide (SMRP)
Sponsors and Collaborators:
Memorial Sloan Kettering Cancer Center
Website Link: https://ClinicalTrials.gov/show/NCT02414269
